Neurodevelopmental disorders are a huge unmet medical need with a high burden for patients and society. Neurolentech´s vision is to become the world-leading company for patient-specific, molecularly defined cellular models in preclinical drug development for autism, epilepsy, and intellectual disability.

Health Care

Life Sciences

Therapeutics

NEUROLENTECH GmbH

NEUROLENTECH GmbH's headquarters in Klosterneuburg, Austria

This department focuses on conducting scientific research and developing innovative solutions to advance knowledge and technology.

��

People (3)

Jobs (0)

Other teams

��������

People (3)

Jobs (0)

Other teams

��